Leadership changes
Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.
Updated Nov 6, 2026
Changes, November 2026
292
Appointments
143
Departures
34
Browse by role
Get new CFO appointments the day the filing lands.
Browse by month
Filters
3,420 changes
| Filing date | Company | Person | Role | Change | Effective date | Source |
|---|---|---|---|---|---|---|
| Sep 28, 2026 | NEUROCRINE BIOSCIENCES INC | Eiry W. Roberts, M.D. | Chief Medical OfficerCMO | Appointed | Sep 28, 2026 | SEC 8-K |
| Sep 28, 2026 | NEUROCRINE BIOSCIENCES INC | Sanjay Keswani, M.D. | Chief Medical OfficerCMO | Departed | Sep 25, 2026 | SEC 8-K |
| Sep 28, 2026 | PAR PACIFIC HOLDINGS, INC. | Richard Creamer | Executive Vice President – Refining and LogisticsExecutive Vice President – Refining and Logistics | Departed | Apr 1, 2027 | SEC 8-K |
| Sep 28, 2026 | QUANTUM CORP /DE/ | James C. Clancy | Chief Operating OfficerCOO | Appointed | Sep 28, 2026 | SEC 8-K |
| Sep 28, 2026 | QUANTUM CORP /DE/ | James C. Clancy | member of the Company’s Board of Directorsmember of the Company’s Board of Directors | Departed | Sep 28, 2026 | SEC 8-K |
| Sep 28, 2026 | SPDR GOLD TRUST | Joan A. Binstock | Board of DirectorsBoard of Directors | Appointed | Sep 28, 2026 | SEC 8-K |
| Sep 28, 2026 | StandardAero, Inc. | Kimberly Ernzen | Chief Operating OfficerCOO | Departed | Sep 28, 2026 | SEC 8-K |
| Sep 28, 2026 | SURF AIR MOBILITY INC. | Jason Secore | Chief Financial OfficerCFO | Appointed | Sep 30, 2026 | SEC 8-K |
| Sep 28, 2026 | SURF AIR MOBILITY INC. | Oliver Reeves | Chief Financial OfficerCFO | Departed | Sep 30, 2026 | SEC 8-K |
| Sep 28, 2026 | SURF AIR MOBILITY INC. | Oliver Reeves | Principal Financial OfficerPrincipal Financial Officer | Departed | Sep 30, 2026 | SEC 8-K |
| Sep 28, 2026 | TELEDYNE TECHNOLOGIES INC | Jason VanWees | Vice ChairmanVice Chairman | Departed | Feb 1, 2027 | SEC 8-K |
| Sep 28, 2026 | Tempest Therapeutics, Inc. | Nancy Freda-Smith | Class III directorClass III director | Appointed | Sep 22, 2026 | SEC 8-K |
| Sep 28, 2026 | Tempest Therapeutics, Inc. | Nicholas Rossettos | Chief Financial OfficerCFO | Departed | Sep 22, 2026 | SEC 8-K |
| Sep 28, 2026 | Tempest Therapeutics, Inc. | Constance Ames | Chief Financial OfficerCFO | Appointed | Sep 22, 2026 | SEC 8-K |
| Sep 28, 2026 | Vestis Corp | Russell Tiejema | Executive Vice President and Chief Financial OfficerCFO | Appointed | Sep 28, 2026 | SEC 8-K |
| Sep 28, 2026 | World Gold Trust | Joan A. Binstock | Board of DirectorsBoard of Directors | Appointed | Sep 28, 2026 | SEC 8-K |
| Sep 29, 2026 | ACUITY INC. (DE) | Nick Tzitzon | directordirector | Appointed | Sep 24, 2026 | SEC 8-K |
| Sep 29, 2026 | Altimmune, Inc. | Richard Menziuso | Vice President, Global Controller and Principal Accounting OfficerVice President, Global Controller and Principal Accounting Officer | Appointed | Sep 29, 2026 | SEC 8-K |
| Sep 29, 2026 | Aquestive Therapeutics, Inc. | Richard J. Daly | director of the Companydirector of the Company | Appointed | Oct 14, 2026 | SEC 8-K |
| Sep 29, 2026 | Arrive AI Inc. | Mark Hamm | Chief Operating OfficerCOO | Departed | Oct 2, 2026 | SEC 8-K |
- NEUROCRINE BIOSCIENCES INCAppointed
Eiry W. Roberts, M.D. CMO
Filed Sep 28, 2026Effective Sep 28, 2026SEC 8-K
- NEUROCRINE BIOSCIENCES INCDeparted
Sanjay Keswani, M.D. CMO
Filed Sep 28, 2026Effective Sep 25, 2026SEC 8-K
- PAR PACIFIC HOLDINGS, INC.Departed
Richard Creamer Executive Vice President – Refining and Logistics
Filed Sep 28, 2026Effective Apr 1, 2027SEC 8-K
- QUANTUM CORP /DE/Appointed
James C. Clancy COO
Filed Sep 28, 2026Effective Sep 28, 2026SEC 8-K
- QUANTUM CORP /DE/Departed
James C. Clancy member of the Company’s Board of Directors
Filed Sep 28, 2026Effective Sep 28, 2026SEC 8-K
- SPDR GOLD TRUSTAppointed
Joan A. Binstock Board of Directors
Filed Sep 28, 2026Effective Sep 28, 2026SEC 8-K
- StandardAero, Inc.Departed
Kimberly Ernzen COO
Filed Sep 28, 2026Effective Sep 28, 2026SEC 8-K
- SURF AIR MOBILITY INC.Appointed
Jason Secore CFO
Filed Sep 28, 2026Effective Sep 30, 2026SEC 8-K
- SURF AIR MOBILITY INC.Departed
Oliver Reeves CFO
Filed Sep 28, 2026Effective Sep 30, 2026SEC 8-K
- SURF AIR MOBILITY INC.Departed
Oliver Reeves Principal Financial Officer
Filed Sep 28, 2026Effective Sep 30, 2026SEC 8-K
- TELEDYNE TECHNOLOGIES INCDeparted
Jason VanWees Vice Chairman
Filed Sep 28, 2026Effective Feb 1, 2027SEC 8-K
- Tempest Therapeutics, Inc.Appointed
Nancy Freda-Smith Class III director
Filed Sep 28, 2026Effective Sep 22, 2026SEC 8-K
- Tempest Therapeutics, Inc.Departed
Nicholas Rossettos CFO
Filed Sep 28, 2026Effective Sep 22, 2026SEC 8-K
- Tempest Therapeutics, Inc.Appointed
Constance Ames CFO
Filed Sep 28, 2026Effective Sep 22, 2026SEC 8-K
- Vestis CorpAppointed
Russell Tiejema CFO
Filed Sep 28, 2026Effective Sep 28, 2026SEC 8-K
- World Gold TrustAppointed
Joan A. Binstock Board of Directors
Filed Sep 28, 2026Effective Sep 28, 2026SEC 8-K
- ACUITY INC. (DE)Appointed
Nick Tzitzon director
Filed Sep 29, 2026Effective Sep 24, 2026SEC 8-K
- Altimmune, Inc.Appointed
Richard Menziuso Vice President, Global Controller and Principal Accounting Officer
Filed Sep 29, 2026Effective Sep 29, 2026SEC 8-K
- Aquestive Therapeutics, Inc.Appointed
Richard J. Daly director of the Company
Filed Sep 29, 2026Effective Oct 14, 2026SEC 8-K
- Arrive AI Inc.Departed
Mark Hamm COO
Filed Sep 29, 2026Effective Oct 2, 2026SEC 8-K